AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30037818
Drug: Ipatasertib 400
RxNorm normalized name: Ipatasertib
DrugBank: Ipatasertib (DB11743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipatasertib 400 mg with abiraterone 1,000 mg
Trial: 30037818
Drug: Ipatasertib 200
RxNorm normalized name: Ipatasertib
DrugBank: Ipatasertib (DB11743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipatasertib 200 mg with abiraterone 1,000 mg
Trial: 30037818
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with abiraterone 1,000 mg
Trial: 24094463
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of AT-III 100 U/kg IV for 20 minutes
Trial: 24094463
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of AT-III 100 U/kg IV for 20 minutes
Trial: 18086050
Drug: smooth-gel hyaluronic
RxNorm normalized name: Derma-Smoothe FS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: smooth-gel hyaluronic acid dermal fillers
Trial: 11887498
Drug: Corticosteroids administered
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids administered systemically in the first two weeks after birth
Trial: 9632998
Drug: Trimethoprim-sulfamethoxazole or
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole or alternative agents
Trial: 7912876
Drug: Dixyrazine (15-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dixyrazine (15-30 mg)
Trial: 7912876
Drug: Diazepam (4-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (4-10 mg)
Trial: 2510135
Drug: Diltiazem 90
RxNorm normalized name: diltiazem 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 90 mg every 8 hours for 5 days
Trial: 2510135
Drug: Encainide 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encainide 25 mg every 8 hours for 5 days
Trial: 1254724
Drug: Gastrin antiserum
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrin antiserum (0.02, 0.1, and 0.5 ml/kg)
Trial: 1254724
Drug: Gastrin antiserum
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrin antiserum (0.1 ml/kg)
Trial: 1254724
Drug: Gastrin antiserum
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrin antiserum (0.2 ml/kg)
Trial: 27045264
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg on-demand (PRN)
Trial: 22998616
Drug: 1 implant
RxNorm normalized name: LEUPROLIDE ACETATE 72 MILLIGRAM In 1 IMPLANT SUBCUTANEOUS IMPLANT [Viadur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 implant (Group 1)
Trial: 22998616
Drug: 2 implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 implants (Group 2)
Trial: 10444231
Drug: Mizolastine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine (10 mg/day)
Trial: 10444231
Drug: Mizolastine (5-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine (5-45 mg)
Trial: 10444231
Drug: First generation
RxNorm normalized name: First generation cephalosporin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First generation antihistamines (clemastine, tripolidine) and second generation antihistamines (terfenadine, cetirizine)
Trial: 1978488
Drug: Remoxipride (30-90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride (30-90 mg, 120-240 mg, 300-600 mg, divided into three doses per day)
Trial: 1978488
Drug: Remoxipride (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride (maximum dose for 4 weeks or more)
Trial: 1978488
Drug: Remoxipride (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride (dose reductions or discontinuations due to adverse symptoms)
Trial: 31190491
Drug: Femoston (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoston (oral estradiol and dydrogesterone tablets)
Trial: 29246219
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of Pycnogenol® twice daily
Trial: 22097612
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 10 mg/d
Trial: 16537846
Drug: Tiotropium plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium plus formoterol once daily
Trial: 16537846
Drug: Tiotropium plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium plus formoterol twice daily
Trial: 12492791
Drug: Bupivacaine 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 6.0 mg + fentanyl 25 micro g
Trial: 12492791
Drug: Bupivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 7.5 mg + fentanyl 25 micro g
Trial: 8095449
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 1 mg of terbutaline (4 puffs)
Trial: 18484252
Drug: Extracorporal shock-wave
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extracorporal shock-wave therapy (ESWT)
Trial: 8256187
Drug: Gentamicin 1.5
RxNorm normalized name: HYDROCORTISONE ACEPONATE 1.11 mg in 1 mL / MICONAZOLE NITRATE 17.4 mg in 1 mL / GENTAMICIN 1.5 mg in 1 mL AURICULAR (OTIC) SUSPENSION [EASOTIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.5 milligrams per kilogram IVPB plus clindamycin 0.9 grams every eight hours IVPB (G/C)
Trial: 8256187
Drug: Gentamicin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin plus clindamycin (G/C)
Trial: 27325103
Drug: CO2 fractional
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 fractional laser photothermolysis followed by 4 weeks topical application of B‐Resorcinol and Glycyrrhetinic acid
Trial: 27325103
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of B‐Resorcinol and Glycyrrhetinic acid only
Trial: 25411293
Drug: Daily 500
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years (including 600 IU vitamin D3)
Trial: 25411293
Drug: Daily 500
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years
Trial: 23290324
Drug: Metadoxine ER
RxNorm normalized name: metadoxine
DrugBank: Metadoxine (DB16554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metadoxine ER 1,400 mg/d for 6 weeks
Trial: 18976162
Drug: Fentanyl 15
RxNorm normalized name: fentaNYL 150 mcg/30 mL-D5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 15 microg/kg + Ondansetron 12 mg
Trial: 18976162
Drug: Fentanyl 12.5
RxNorm normalized name: FENTANYL 12.5MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 12.5 microg/kg + Ketorolac 1.5 mg/kg + Ondansetron 12 mg
Trial: 18976162
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 microg/kg + Ketorolac 3 mg/kg + Ondansetron 12 mg
Trial: 16096176
Drug: Gonadotropin releasing
RxNorm normalized name: Gonadotropin releasing factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropin releasing hormone (GnRH, goserelin 3.6 mg) administered subcutaneously every 28 days for 12 weeks
Trial: 11835027
Drug: Intravenous testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous testosterone (2 doses designed to increase testosterone 2 or 6 times baseline)
Trial: 3034034
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg (3 times at 12-hour intervals)
Trial: 3034034
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg daily for 2 weeks
Trial: 27391675
Drug: Behavioural Activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural Activation Treatment for Depression (Activate) - 10 individual 60-min therapy sessions with a psychologist, in addition to treatment as usual (TAU)
Trial: 18658066
Drug: Language-Focused Curriculum
RxNorm normalized name: AVOBENZONE 0.2 g in 1 g / BUTYLENE GLYCOL 0.1 g in 1 g TOPICAL CREAM [Focused Corrective]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Language-Focused Curriculum (LFC) implemented by treatment teachers for an academic year.
Trial: 12888401
Drug: Oral presentation
RxNorm normalized name: Gas-X Prevention Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral presentation (8 sessions)
Trial: 10573549
Drug: Atole (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atole (high energy, high protein supplement)
Trial: 10573549
Drug: Fresco (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresco (low energy, no-protein supplement)
Trial: 8767568
Drug: Preventive group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive group (100 mg tramadol at extubation + continuous infusion of 200 mg tramadol)
Trial: 31079083
Drug: Acupuncture with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture with Doin therapy
Trial: 25590331
Drug: Public health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Public health intervention promoting expedited partner therapy (EPT) with free patient-delivered partner therapy (PDPT) available to clinicians.
Trial: 23688367
Drug: Integrated Pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Pain Management Program (IPMP) for staff and residents, consisting of 8 weeks of activities including gardening therapy and physiotherapy exercise.
Trial: 20027365
Drug: Tenoten and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoten and Tenoten (pediatric formulation)
Trial: 17578751
Drug: Glucosamine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine (1500 mg per day)
Trial: 15539864
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amitriptyline and citalopram
Trial: 11314213
Drug: 3% benzalkonium
RxNorm normalized name: BENZALKONIUM CHLORIDE 5.2 mg TOPICAL CLOTH [Antiseptic sanitizing wipes (0.13% Benzalkonium Chloride)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% benzalkonium chloride solution
Trial: 9503181
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus ticlopidine (250 mg)
Trial: 10953
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol at a dose of 1 mg/kg
Trial: 10953
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol at a dose of 2 mg/kg
Trial: 10953
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol at a dose of 1 mg/kg and 2 mg/kg
Trial: 31811662
Drug: Inhaled Technosphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled Technosphere Insulin
Trial: 31811662
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin aspart
Trial: 18840027
Drug: Venlafaxine 37.5
RxNorm normalized name: venlafaxine 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 37.5 mg
Trial: 12574793
Drug: Delapril 30
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delapril 30 mg + Indapamide 1.25 mg (D+I)
Trial: 12574793
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg + Hydrochlorothiazide 15 mg (C+H)
Trial: 1545660
Drug: CAAD (diphenhydramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAAD (diphenhydramine hydrochloride, 50 mg; pseudoephedrine hydrochloride, 60 mg; acetaminophen, 1 g in 10% ethanol)
Trial: 1545660
Drug: Diphenhydramine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (single dose)
Trial: 3872241
Drug: Endoscopic Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic Nd:YAG laser therapy
Trial: 3872241
Drug: Sham endoscopy
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham endoscopy and standard medical therapy (Control)
Trial: 24100705
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment for back pain and VCF
Trial: 22425507
Drug: Risedronate, 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate, 35 mg once weekly
Trial: 20868284
Drug: Egg-derived trivalent
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg-derived trivalent inactivated vaccine (TIV)
Trial: 19024795
Drug: Glabridin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glabridin (60 mg)
Trial: 12879120
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic therapies
Trial: 8973995
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg) with prednisone (40 mg)
Trial: 8973995
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg) with prednisone (40 mg)
Trial: 8973995
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with prednisone (40 mg)
Trial: 1283847
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy (single-agent tamoxifen)
Trial: 1283847
Drug: Chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combined with endocrine therapy
Trial: 1283847
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of chemotherapy with colony-stimulating factors and bone marrow transplantation
Trial: 1283847
Drug: Combined endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined endocrine therapy
Trial: 3931537
Drug: Insulin +
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin + glibenclamide 5 mg twice daily
Trial: 30646879
Drug: Group schema-focused
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group schema-focused therapy enriched with psychomotor therapy (SFT + PMT)
Trial: 28597302
Drug: Pre-operative hypertension
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative hypertension treatment
Trial: 23644914
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch applied to smokers during nicotine withdrawal
Trial: 23644914
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch applied to smokers
Trial: 23644914
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch applied to non-smokers
Trial: 22333098
Drug: Marvelon (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marvelon (30 µg ethinylestradiol and 150 µg desogestrel) for 21 days
Trial: 22333098
Drug: Progynova 2
RxNorm normalized name: Progynova 2 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progynova 2 mg/d for 21 days and depogesterone 10 mg/d for last 5 days
Trial: 15303255
Drug: Ylang-ylang oil
RxNorm normalized name: Ylang-ylang oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ylang-ylang oil (Cananga odorata) inhalation
Trial: 9813876
Drug: 20% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% glucose polymer (G)
Trial: 3234614
Drug: Trimoprostil 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimoprostil 3 mg twice daily
Trial: 3234614
Drug: Trimoprostil 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimoprostil 3 mg at bedtime
Trial: 31821741
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of immunosuppressive drugs
Trial: 26335087
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (DHA) 1,470 mg/d plus 147 mg/d of eicosapentaenoic acid (EPA)
Trial: 23061976
Drug: T/LAIV (trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T/LAIV (trivalent live attenuated influenza vaccine)
Trial: 18354393
Drug: Depot leuprolide
RxNorm normalized name: leuprolide acetate Injectable Suspension [Lupron Depot]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depot leuprolide acetate (Lupron) every 4 weeks for 3 months (men) or 5 months (women) + testosterone enanthate (200 mg intramuscularly) every 2 weeks for 1 month (men)
Trial: 17006278
Drug: Intranasal CAIV-T
RxNorm normalized name: T-5224
DrugBank: T-5224 (DB05998)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal CAIV-T (live attenuated cold-adapted influenza vaccine)
Trial: 17006278
Drug: Injectable TIV
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable TIV (trivalent inactivated influenza vaccine)
Trial: 17006278
Drug: Intranasal CAIV-T
RxNorm normalized name: T-5224
DrugBank: T-5224 (DB05998)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal CAIV-T
Trial: 17006278
Drug: Intranasal CAIV-T
RxNorm normalized name: T-5224
DrugBank: T-5224 (DB05998)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal CAIV-T and Injectable TIV
Trial: 9201603
Drug: Glutathione i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutathione i.v. administration (1 g/m2 bolus + 1 g/m2 in 2 h)
Trial: 9201603
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance test + glutathione administration
Trial: 3426836
Drug: L-phenylalanine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-phenylalanine (high phe)
Trial: 3426836
Drug: L-alanine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-alanine (low phe)
Trial: 30002145
Drug: Rivaroxaban (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (20 mg once daily, or 15 mg based on kidney function)
Trial: 30002145
Drug: Warfarin (international
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (international normalized ratio target 2.5)
Trial: 30002145
Drug: Rivaroxaban vs
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rivaroxaban vs Warfarin
Trial: 22672058
Drug: Inulin 10
RxNorm normalized name: inulin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin 10 g
Trial: 22672058
Drug: Inulin 20
RxNorm normalized name: inulin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin 20 g
Trial: 22672058
Drug: SGF 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SGF 40 g (acute consumption)
Trial: 22672058
Drug: SGF 65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SGF 65 g (spread over the day)
Trial: 17927795
Drug: ReCell treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ReCell treatment
Trial: 17186712
Drug: Oxybutynin (immediate-release)
RxNorm normalized name: oxybutynin Extended Release Oral Tablet
DrugBank: Oxybutynin (DB01062)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxybutynin (immediate-release)
Trial: 17186712
Drug: Tolterodine (immediate-release)
DrugBank: Tolterodine (DB01036)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tolterodine (immediate-release)
Trial: 17186712
Drug: Extended-release formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release formulations of Tolterodine or Oxybutynin
Trial: 3082257
Drug: Cromolyn sodium
RxNorm normalized name: Cromolyn Sodium
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium (CS) pressurized aerosol, 1 mg per puff, 2 puffs, four times daily for 4 weeks
Trial: 3082257
Drug: Placebo, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 2 puffs, four times daily for 4 weeks
Trial: 31520633
Drug: Adjuvant Radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant Radiation Therapy (RT)
Trial: 31520633
Drug: No Adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Adjuvant Radiation Therapy (RT)
Trial: 27449925
Drug: Vitamin D3-enriched
RxNorm normalized name: vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3-enriched Gouda-type cheese (60 g providing 5.7 μg of vitamin D3 daily)
Trial: 26860022
Drug: I-GEL
RxNorm normalized name: Di-Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-GEL
Trial: 23167912
Drug: M‐MIST with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M‐MIST with rhPDGF‐BB gel
Trial: 21296957
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (5.0 g daily, containing 2.0 g of EPA and 1.0 g of DHA)
Trial: 21296957
Drug: Placebo oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oil (5.0 g of corn/soy mixture)
Trial: 11374698
Drug: N2O/O2 inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N2O/O2 inhalation (50% N2O/O2)